J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

What do you think the new year has in store for us? By Michael Gonchar Look closely at this image, stripped of its caption, and join the moderated conversation about what you and other students see.

The leader of the anti-immigrant Freedom Party of Austria, founded by former Nazis in the 1950s, was expected to be asked to enter into talks to form a new government. In a year marked by wars ...